文献速递鼻科耳科与耳神经

鼻塞的手术矫正及其对咽鼓管功能障碍症状的影响

Surgical Correction of Nasal Obstruction and Its Effect on Eustachian Tube Dysfunction Symptoms.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-11-30

回顾性图表回顾纳入259例因非鼻窦炎性鼻塞行鼻中隔成形术和/或下鼻甲减容术的患者,术前37.5%存在临床显著咽鼓管功能障碍(ETD)症状。该组ETDQ-7评分从基线23.3±7.6显著降至术后1周19.1±9.1、1个月16.5±8.0、3个月16.2±7.8、6个月16.7±10.4(均P < .01)。

要点

  • 鼻塞手术患者术前37.5%存在临床显著ETD症状(ETDQ-7 > 14.5)。
  • 基线有ETD症状者术后各时间点ETDQ-7均较基线显著改善(均P < .01)。
  • 基线无ETD症状者术后1周ETDQ-7急性恶化,其余时间点无显著变化。

核心结论

  • 鼻塞的手术矫正可能改善咽鼓管功能障碍症状。

研究设计与样本

  • 回顾性图表回顾,单中心学术中心,纳入259例因非鼻窦炎性鼻塞行鼻中隔成形术、下鼻甲减容术或两者联合的患者,排除慢性鼻窦炎患者。

主要发现

  • 术前37.5%的鼻塞患者存在临床显著ETD症状(ETDQ-7 > 14.5)。
  • 基线有ETD症状者ETDQ-7从基线23.3±7.6降至术后1周19.1±9.1、1个月16.5±8.0、3个月16.2±7.8、6个月16.7±10.4(均P < .01)。
  • 基线无ETD症状者(基线ETDQ-7 9.1±2.3)术后各时间点ETDQ-7无显著变化,但术后1周出现急性恶化(10.7±5.1,P < .001)。
  • 回归分析显示较高术前ETDQ-7评分(β = -0.84,95%CI:-1.10至-0.59)和术后抗组胺喷雾使用(β = -8.70,95%CI:-14.20至-3.20)与ETDQ-7改善相关。
  • 合并GERD(β = 7.50,95%CI:3.42-11.58)和哮喘(β = 5.62,95%CI:0.80-10.45)与ETDQ-7改善呈负相关。

关键数值与推荐

  • 术前ETDQ-7 > 14.5定义为存在临床显著ETD症状。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate how eustachian tube dysfunction symptoms change following surgical treatment of nonsinusitis-related nasal obstruction. STUDY DESIGN: Retrospective chart review. SETTING: Single academic center. METHODS: We assessed patients who underwent septoplasty, turbinate reduction, or both for nasal obstruction. Chronic sinusitis patients were excluded. Eustachian tube dysfunction (ETD) symptoms were studied using the Eustachian Tube Dysfunction Questionnaire (ETDQ-7), collected preoperatively and postoperatively (1 week, 1 month, 3 months, 6 months postop). Patients with preoperative ETDQ-7 > 14.5 were considered to have clinically significant symptoms. Sinonasal outcomes test scores were also assessed. Pre- and postoperative ETDQ-7 scores were compared using t test. Multivariate linear regression analysis identified factors associated with ETDQ-7 change. RESULTS: We analyzed 259 patients. Preoperatively, 37.5% of patients with nasal obstruction had clinically significant ETD symptoms. These patients exhibited significant improvement in ETDQ-7 at all postoperative timepoints from 23.3 ± 7.6 at baseline to 19.1 ± 9.1 at 1 week, 16.5 ± 8.0 at 1 month, 16.2 ± 7.8 at 3 months, and 16.7 ± 10.4 at 6 months (all P < .01). In patients without baseline ETD symptoms, (baseline ETDQ-7: 9.1 ± 2.3) ETDQ-7 scores did not change significantly at postoperative timepoints, except for an acute worsening at 1 week postoperatively (10.7 ± 5.1, P < .001). Regression analysis showed that higher preoperative ETDQ-7 score (β = -0.84, 95% confidence interval [CI]: -1.10 to -0.59) and postoperative antihistamine spray usage (β = -8.70, 95% CI: -14.20 to -3.20) were associated with ETDQ-7 improvement, while comorbid GERD (β = 7.50, 95% CI: 3.42-11.58) and asthma (β = 5.62, 95% CI: 0.80-10.45) were negatively associated with improvement. CONCLUSION: Surgical correction of nasal obstruction may improve ETD symptoms.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Daum R, Grimm D, Castro Silva BR, et al. Surgical Correction of Nasal Obstruction and Its Effect on Eustachian Tube Dysfunction Symptoms. Otolaryngol Head Neck Surg. 2023. PMID: 38037398. doi:10.1002/ohn.607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。